Cadila Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 120.65 Cr
as on 23-10-2024
- Paid Up Capital ₹ 80.01 Cr
as on 23-10-2024
- Company Age 33 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3,792.11 Cr
as on 23-10-2024
- Satisfied Charges ₹ 2,932.95 Cr
as on 23-10-2024
- Revenue -0.44%
(FY 2023)
- Profit -93.85%
(FY 2023)
- Ebitda -70.08%
(FY 2023)
- Net Worth 54.21%
(FY 2023)
- Total Assets 40.81%
(FY 2023)
About Cadila Pharmaceuticals
The Corporate was formerly known as Nova Biostic (India) Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 120.65 Cr and a paid-up capital of Rs 80.01 Cr.
The company currently has active open charges totaling ₹3,792.11 Cr. The company has closed loans amounting to ₹2,932.95 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Cadila Pharmaceuticals Limited India are Kamlesh Shah as CFO and Renuka Upadhyay as Company Secretary. Girdhar Balwani, Rajiv Modi, Ramesh Choksi, and Four other members serve as directors at the Company.
- CIN/LLPIN
U24231GJ1991PLC015132
- Company No.
015132
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
28 Feb 1991
- Date of AGM
25 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Cadila Pharmaceuticals Limited offer?
Cadila Pharmaceuticals Limited offers a wide range of products and services, including Health Conditions, Cold & Cough, Skin Care, Mosquito Repellents, Facewash, Respiratory Care, Sunscreen Products, Pain Relief, Women Care, Mother Care.
Who are the key members and board of directors at Cadila Pharmaceuticals?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajiv Modi  | Managing Director | 28-Feb-1991 | Current |
| Kamlesh Shah | CFO | 22-Dec-2022 | Current |
| Renuka Upadhyay | Company Secretary | 16-Aug-2024 | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Girdhar Balwani | Director | 01-May-2017 | Current |
| Ramesh Choksi | Whole-Time Director | 07-Feb-2014 | Current |
| Abhijat Sheth | Director | 31-Aug-2018 | Current |
| Parul Shah | Director | 16-Apr-2024 | Current |
Rajiv Modi  | Director | 16-Aug-2024 | Current |
| Manvantkumar Rami | Director | 16-Apr-2024 | Current |
Financial Performance and Corporate Structure Insights of Cadila Pharmaceuticals.
Cadila Pharmaceuticals Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 0.44% decrease. The company also saw a substantial fall in profitability, with a 93.85% decrease in profit. The company's net worth Soared by an impressive increase of 54.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cadila Pharmaceuticals?
In 2023, Cadila Pharmaceuticals had a promoter holding of 100.00%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Irm Enterprises Private LimitedActive 15 years 3 monthsRajiv Modi, Ramesh Choksi and 2 more are mutual person
Redefine Leisure Private LimitedActive 16 years 10 monthsRajiv Modi and Ramesh Choksi are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 15 Apr 2024 | ₹1,569.35 Cr | Open |
Canara Bank Creation Date: 29 Sep 2023 | ₹300.00 Cr | Open |
Hdfc Bank Limited Creation Date: 27 Jun 2023 | ₹63.75 Cr | Open |
How Many Employees Work at Cadila Pharmaceuticals?
Cadila Pharmaceuticals has a workforce of 5833 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cadila Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cadila Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
